CXO Talks: Josh Wittner from Gene By Gene in a Riveting Conversation with PharmaShots

Shots: In this captivating episode of the CXO Talks Podcast, PharmaShots sits down with Josh Wittner, President, North America at Gene By Gene, to explore the company’s evolution and impact in the field of genetic testing Gene By Gene, a leading commercial genetic testing company, delivers cutting-edge genetic data services spanning a broad range of…

ByAditya SinghOctober 13, 2025

THOUGHTSPOT

Trends in Biopharma: The Upsurge in Multi-Omics Analysis

Last month, we explored four key trends shaping the biopharma industry in 2025. In this follow-up, we spotlight the evolving role of multi-omics analysis—a field rapidly transforming how diseases are understood, diagnosed, and treated. In 2024, the global multi-omics market was valued at $2.72 billion and is projected to reach $9.91 billion by 2033, growing…

BySaurabh ChaubeySeptember 10, 2025

EVENTS

Discovery & Development Summit Asia 2025

Discovery & Development Summit Asia 2025 is Global Engage’s inaugural platform that brings together the Drug Discovery & Development, Nucleic Acid Therapeutics and Precision Medicine congresses. This summit allows the exploration of the full spectrum of therapeutic innovation, from early-stage discovery to clinical translation and commercialization. Attendees will gain insights into assay development, screening technologies,…

BySaurabh ChaubeyAugust 5, 2025

CXO Talks: Josh Wittner from Gene By Gene in a Riveting Conversation with PharmaShots

Trends in Biopharma: The Upsurge in Multi-Omics Analysis

Discovery & Development Summit Asia 2025

Contact US

FOLLOW US